{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T07:44:56Z","timestamp":1794296696209,"version":"4.9.0"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1097\/rlu.0000000000001672","type":"journal-article","created":{"date-parts":[[2017,5,6]],"date-time":"2017-05-06T18:07:54Z","timestamp":1494094074000},"page":"e322-e327","source":"Crossref","is-referenced-by-count":36,"title":["Evaluation of Practical Interpretation Hurdles in 68Ga-PSMA PET\/CT in 55 Patients"],"prefix":"10.1097","volume":"42","author":[{"given":"Julian","family":"Kirchner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedikt Michael","family":"Schaarschmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lino Morris","family":"Sawicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Heusch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubertus","family":"Hautzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Ermert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Rabenalt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Antoch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Buchbender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-28-20210204","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.ejca.2009.12.014","article-title":"Estimates of cancer incidence and mortality in Europe in 2008","volume":"46","author":"Ferlay","year":"2010","journal-title":"Eur J Cancer"},{"key":"R2-28-20210204","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3322\/caac.21208","article-title":"Cancer statistics, 2014","volume":"64","author":"Siegel","year":"2014","journal-title":"CA Cancer J Clin"},{"key":"R3-28-20210204","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1007\/s00330-014-3276-9","article-title":"MR-sequences for prostate cancer diagnostics: validation based on the PI-RADS scoring system and targeted MR-guided in-bore biopsy","volume":"24","author":"Schimmoller","year":"2014","journal-title":"Eur Radiol"},{"key":"R4-28-20210204","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.2967\/jnumed.116.173492","article-title":"Value of 68Ga-PSMA HBED-CC PET for the assessment of lymph node metastases in prostate cancer patients with biochemical recurrence: comparison with histopathology after salvage lymphadenectomy","volume":"57","author":"Rauscher","year":"2016","journal-title":"J Nucl Med"},{"key":"R5-28-20210204","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1053\/j.semnuclmed.2005.09.001","article-title":"Nuclear medicine studies of the prostate, testes, and bladder","volume":"36","author":"Jana","year":"2006","journal-title":"Semin Nucl Med"},{"key":"R6-28-20210204","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1053\/j.semnuclmed.2010.08.005","article-title":"PET\/CT imaging and radioimmunotherapy of prostate cancer","volume":"41","author":"Bouchelouche","year":"2011","journal-title":"Semin Nucl Med"},{"key":"R7-28-20210204","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.eururo.2013.04.019","article-title":"The role of 11C-choline and 18F-fluorocholine positron emission tomography (PET) and PET\/CT in prostate cancer: a systematic review and meta-analysis","volume":"64","author":"Umbehr","year":"2013","journal-title":"Eur Urol"},{"key":"R8-28-20210204","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s12149-013-0731-7","article-title":"Choline PET\/CT for imaging prostate cancer: an update","volume":"27","author":"Kitajima","year":"2013","journal-title":"Ann Nucl Med"},{"key":"R9-28-20210204","doi-asserted-by":"crossref","first-page":"951","DOI":"10.2174\/1568026611313080008","article-title":"PET imaging in prostate cancer: focus on prostate-specific membrane antigen","volume":"13","author":"Mease","year":"2013","journal-title":"Curr Top Med Chem"},{"key":"R10-28-20210204","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.2967\/jnumed.115.154336","article-title":"18F-DCFBC PET\/CT for PSMA-based detection and characterization of primary prostate cancer","volume":"56","author":"Rowe","year":"2015","journal-title":"J Nucl Med"},{"key":"R11-28-20210204","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1007\/s00259-016-3366-9","article-title":"Detection of recurrent prostate cancer lesions before salvage lymphadenectomy is more accurate with (68)Ga-PSMA-HBED-CC than with (18)F-Fluoroethylcholine PET\/CT","volume":"43","author":"Pfister","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R12-28-20210204","doi-asserted-by":"crossref","first-page":"668","DOI":"10.2967\/jnumed.115.154153","article-title":"Evaluation of hybrid 68Ga-PSMA ligand PET\/CT in 248 patients with biochemical recurrence after radical prostatectomy","volume":"56","author":"Eiber","year":"2015","journal-title":"J Nucl Med"},{"key":"R13-28-20210204","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00259-014-2949-6","article-title":"The diagnostic value of PET\/CT imaging with the (68)Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer","volume":"42","author":"Afshar-Oromieh","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R14-28-20210204","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/RLU.0000000000000709","article-title":"Detection of brain metastasis with 68Ga-labeled PSMA ligand PET\/CT: a novel radiotracer for imaging of prostate carcinoma","volume":"40","author":"Chakraborty","year":"2015","journal-title":"Clin Nucl Med"},{"key":"R15-28-20210204","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.eururo.2015.06.010","article-title":"Initial experience of (68)Ga-PSMA PET\/CT imaging in high-risk prostate cancer patients prior to radical prostatectomy","volume":"69","author":"Bud\u00e4us","year":"2016","journal-title":"Eur Urol"},{"key":"R16-28-20210204","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s00259-014-2915-3","article-title":"[(68)Ga]PSMA-HBED uptake mimicking lymph node metastasis in coeliac ganglia: an important pitfall in clinical practice","volume":"42","author":"Krohn","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R17-28-20210204","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1097\/RLU.0000000000000827","article-title":"Prostate-specific membrane antigen PET\/CT in splenic sarcoidosis","volume":"40","author":"Kobe","year":"2015","journal-title":"Clin Nucl Med"},{"key":"R18-28-20210204","doi-asserted-by":"crossref","first-page":"81","DOI":"10.18383\/j.tom.2015.00169","article-title":"Uptake of 18F-DCFPyL in Paget's disease of bone, an important potential pitfall in clinical interpretation of PSMA PET studies","volume":"1","author":"Rowe","year":"2015","journal-title":"Tomography"},{"key":"R19-28-20210204","doi-asserted-by":"crossref","first-page":"e449","DOI":"10.1097\/RLU.0000000000001291","article-title":"Subacute stroke mimicking cerebral metastasis in 68Ga-PSMA-HBED-CC PET\/CT","volume":"41","author":"Noto","year":"2016","journal-title":"Clin Nucl Med"},{"key":"R20-28-20210204","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1007\/s00259-015-3065-y","article-title":"First evidence of PSMA expression in differentiated thyroid cancer using [68Ga]PSMA-HBED-CC PET\/CT","volume":"42","author":"Verburg","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R21-28-20210204","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1097\/RLU.0000000000001148","article-title":"PSMA expression in papillary thyroid carcinoma: opening a new horizon in management of thyroid cancer?","volume":"41","author":"Taywade","year":"2016","journal-title":"Clin Nucl Med"},{"key":"R22-28-20210204","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s00259-016-3360-2","article-title":"Diagnostic potential of PET\/CT using a 68Ga-labelled prostate-specific membrane antigen ligand in whole-body staging of renal cell carcinoma: initial experience","volume":"44","author":"Sawicki","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R23-28-20210204","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s00259-015-3297-x","article-title":"(68)Ga-PSMA PET\/CT imaging in primary hepatocellular carcinoma","volume":"43","author":"Sasikumar","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R24-28-20210204","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/RLU.0000000000001139","article-title":"Elevated 68Ga prostate-specific membrane antigen activity in metastatic non-small cell lung cancer","volume":"41","author":"Shetty","year":"2016","journal-title":"Clin Nucl Med"},{"key":"R25-28-20210204","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s00259-014-2921-5","article-title":"In vivo visualization of prostate-specific membrane antigen in glioblastoma","volume":"42","author":"Schwenck","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R26-28-20210204","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1475-2867-14-26","article-title":"Prostate specific membrane antigen (PSMA) expression in primary gliomas and breast cancer brain metastases","volume":"14","author":"Nomura","year":"2014","journal-title":"Cancer Cell Int"},{"key":"R27-28-20210204","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0090-4295(98)00278-7","article-title":"Prostate-specific membrane antigen expression is greatest in prostate adenocarcinoma and lymph node metastases","volume":"52","author":"Sweat","year":"1998","journal-title":"Urology"},{"key":"R28-28-20210204","first-page":"81","article-title":"Prostate-specific membrane antigen expression in normal and malignant human tissues","volume":"3","author":"Silver","year":"1997","journal-title":"Clin Cancer Res"},{"key":"R29-28-20210204","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1007\/s00268-005-0544-5","article-title":"Expression of prostate-specific membrane antigen in normal and malignant human tissues","volume":"30","author":"Kinoshita","year":"2006","journal-title":"World J Surg"},{"key":"R30-28-20210204","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/MNM.0000000000000290","article-title":"Evaluation of PSMA PET\/CT imaging using a 68Ga-HBED-CC ligand in patients with prostate cancer and the value of early pelvic imaging","volume":"36","author":"Kabasakal","year":"2015","journal-title":"Nucl Med Commun"},{"key":"R31-28-20210204","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/RLU.0000000000001220","article-title":"In vivo visualization of prostate-specific membrane antigen in adenoid cystic carcinoma of the salivary gland","volume":"41","author":"Lutje","year":"2016","journal-title":"Clin Nucl Med"},{"key":"R32-28-20210204","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/RLU.0000000000001192","article-title":"Desmoid tumor showing intense uptake on 68Ga PSMA-HBED-CC PET\/CT","volume":"41","author":"Kanthan","year":"2016","journal-title":"Clin Nucl Med"},{"key":"R33-28-20210204","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/RLU.0000000000001169","article-title":"Follicular lymphoma showing avid uptake on 68Ga PSMA-HBED-CC PET\/CT","volume":"41","author":"Kanthan","year":"2016","journal-title":"Clin Nucl Med"},{"key":"R34-28-20210204","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/pros.10319","article-title":"Comparative analysis of prostate-specific membrane antigen (PSMA) versus a prostate-specific membrane antigen-like gene","volume":"58","author":"O'Keefe","year":"2004","journal-title":"Prostate"},{"key":"R35-28-20210204","doi-asserted-by":"crossref","first-page":"557","DOI":"10.2967\/jnumed.115.168393","article-title":"Pilot comparison of 68Ga-RM2 PET and 68Ga-PSMA-11 PET in Patients with biochemically recurrent prostate cancer","volume":"57","author":"Minamimoto","year":"2016","journal-title":"J Nucl Med"},{"key":"R36-28-20210204","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1038\/modpathol.2008.143","article-title":"Prostate-specific membrane antigen expression in regeneration and repair","volume":"21","author":"Gordon","year":"2008","journal-title":"Mod Pathol"},{"key":"R37-28-20210204","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/S0140-6736(05)61125-7","article-title":"Prostate-specific membrane antigen expression in the duodenum: implications in coeliac disease and immunotherapy for prostate cancer","volume":"351","author":"Maraj","year":"1998","journal-title":"Lancet"},{"key":"R38-28-20210204","doi-asserted-by":"crossref","first-page":"e167","DOI":"10.1097\/RLU.0000000000001072","article-title":"Rectal carcinoma on 68Ga-PSMA PET\/CT","volume":"41","author":"Huang","year":"2016","journal-title":"Clin Nucl Med"},{"key":"R39-28-20210204","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/RLU.0000000000001084","article-title":"Follicular thyroid adenoma showing avid uptake on 68Ga PSMA-HBED-CC PET\/CT","volume":"41","author":"Kanthan","year":"2016","journal-title":"Clin Nucl Med"},{"key":"R40-28-20210204","first-page":"1848","article-title":"Fibrous dysplasia. Pathophysiology, evaluation, and treatment","volume":"87","author":"DiCaprio","year":"2005","journal-title":"J Bone Joint Surg Am"},{"key":"R41-28-20210204","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00259-015-3236-x","article-title":"Paget bone disease demonstrated on (68)Ga-PSMA ligand PET\/CT","volume":"43","author":"Artigas","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000001672","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T06:18:54Z","timestamp":1620973134000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003072-201707000-00028"}},"subtitle":["Physiological Tracer Distribution and Incidental Tracer Uptake"],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":41,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000001672","relation":{},"ISSN":["0363-9762"],"issn-type":[{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]}}}